Cancer

2024 ISS National Lab Annual Report Highlights Momentum in Space-Based R&D

ISS National Lab Delivers More Than 100 Payloads to Laboratory in Low Earth Orbit and Expands Resources to Dozens of…

11 months ago

Cordance Medical and EXACT Therapeutics Announce Early Encouraging Data in Brain Cancer Mice Model

MOUNTAIN VIEW, Calif. and OSLO, Norway, Jan. 28, 2025 /PRNewswire/ -- Cordance Medical, a pioneer in non-invasive medical technologies for…

11 months ago

Cooper University Health Care Breaks Ground on First Phase of $3 Billion “Project Imagine” Expansion in Camden

Camden, New Jersey--(Newsfile Corp. - January 28, 2025) - Today, Cooper University Health Care held a groundbreaking ceremony on the…

11 months ago

Definitive JSCDM Article Shows the Power and Value of nCartes EHR-to-EDC

FREMONT, Calif., Jan. 28, 2025 /PRNewswire/ -- Automating data capture by leveraging electronic health records can significantly improve data quality…

11 months ago

SOPHiA GENETICS Launches Comprehensive MRD Tracking Capabilities

The cutting-edge OncoPortal™ Mutation Tracker add-on module enables precision monitoring of evolving genomic cancer drivers BOSTON, MA and ROLLE, Switzerland,…

11 months ago

Okomera to Present Automated Desktop Organoid Screening Instrument for Oncology Drug Discovery at SLAS 2025 in San Diego

PARIS, Jan. 28, 2025 /PRNewswire/ -- Okomera is a biotech startup developing cutting-edge solutions for oncology drug discovery and will…

11 months ago

Lantheus to Acquire Evergreen Theragnostics for Upfront Payment of $250 Million to Drive Strategic Evolution into Fully Integrated Radiopharmaceutical Leader

Advances radiopharmaceutical leadership with addition of scalable manufacturing infrastructure and end-to-end clinical development capabilities Adds OCTEVY™, a registrational-stage diagnostic asset,…

11 months ago

Persephone Biosciences Announces Full Enrollment in AMBROSIA Food as Medicine Study

- 400 participants with a medium-to-high risk of developing colorectal cancer (CRC) have been enrolled across two arms - -…

11 months ago

Allogene Therapeutics Secures U.S. FDA IND Clearance for ALLO-329, Advancing its Next-Generation Allogeneic CAR T into Autoimmune Diseases

Dual-Targeted CD19/CD70 Allogeneic CAR T: Best-in-Class Design to Enhance Therapeutic Benefit and Expand Treatment Potential Across a Range of Autoimmune…

11 months ago

Eterna Therapeutics Announces Expansion of Scientific Advisory Board

Dr. Jerome Zeldis and Dr. Blythe Sather bring exceptional backgrounds in cell therapy and solid tumorsCAMBRIDGE, Mass., Jan. 28, 2025…

11 months ago